ArticleBone2017

The impact of SGLT2 inhibitors, compared with insulin, on diabetic bone disease in a mouse model of type 1 diabetes.

Kathryn M Thrailkill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.